Feb 07, 2014
R370m shot in arm for vaccine researchBack
Cape Town|Africa|BMGF Global Health Programme|Malaria Venture|Projects|Strategic Health Innovation Partnership|System|Africa|South Africa|Grootte Schuur Hospital|University Of Cape Town|Chemical Compound|Health Solutions|Solutions|HIV|HIV/Aids|Infectious Diseases|Malaria|TB|Tuberculosis|Infrastructure|Kelly Chibale|Salim Abdool Karim|Trevor Mundel|Yogan Pillay|Drug Discovery
© Reuse this
The BMGF says it is funding innovative, African-led research at the Medical Research Council (MRC) and the University of Cape Town’s Drug Discovery and Development Centre, H3-D.
“South Africa has world-class researchers and the infrastructure necessary to develop the kinds of innovative health solutions needed to accelerate progress [in the fight] against TB, HIV, malaria and other infectious diseases,” said BMGF Global Health Programme president Trevor Mundel at the announcement in Cape Town late last month.
H3-D is to receive R55-million from the BMGF over a five-year period. The cutting- edge centre, in collaboration with the Medicines for Malaria Venture, recently announced the discovery of a novel chemical compound which has the potential to impact on both the control and eradication of malaria.
The MRC is to receive about R125-million from the BMGF for its Strategic Health Innovation Partnership (SHIP) unit to lead and fund world-class research aimed at developing Aids and TB vaccines.
“The MRC’s initiative to create the SHIP gives South African scientists a unique opportunity to lead the process of developing new technologies to improve health,” said MRC president Professor Salim Abdool Karim.
South African scientists have been proving themselves on the global stage. The malaria compound has garnered international interest. Testing will begin at Grootte Schuur Hospital, in Cape Town, within the next few months. The drug will be given to healthy volunteers.
H3-D founder and director Professor Kelly Chibale said the ability to test the drug in clinical trials was a significant leap.
“It’s extremely important that research is happening in Africa led by Africans. People don’t think of Africa as a source of innovation. But we need to change this. We’ve shown that we can discover drugs, develop them and test them in the system.”
H3-D is steeped in research into HIV/Aids, TB and malaria, while the SHIP intends to fund six to ten projects in the vaccine space.
“Within five years, the SHIP will have a bigger budget than the rest of the MRC,” said Karim, adding that research into infectious diseases needed big money.
“You can’t get moving in development with piddling amounts of money. You need muscle. If we want to develop even one product, we need hundreds of millions of rands to see it through to completion,” said Karim.
The two partnerships have been backed by the departments of Science and Technology and Health.
South Africa has the highest incidence of TB in the world, with 400 000 new smear-positive TB cases recorded every year, while HIV remains a problem.
“We have made great strides [in combating] HIV, but we still have a lot of new infections,” said Yogan Pillay, the deputy director- general for HIV/Aids and TB in the national Department of Health.
Edited by: Martin Zhuwakinyu© Reuse this Comment Guidelines (150 word limit)
Other News This Week News
Recent Research Reports
Defence 2014: A review of South Africa's defence industry (PDF Report)
Creamer Media’s Defence 2014 report examines South Africa’s defence industry, with particular focus on the key participants in the sector, the innovations that have come out of the sector, local and export demand, South Africa’s controversial multibillion-rand...
Road and Rail 2014: A review of South Africa's road and rail infrastructure (PDF report)
Creamer Media’s Road and Rail 2014 report examines South Africa’s road and rail transport system, with particular focus on the size and state of the country’s road and rail network, the funding and maintenance of these respective networks, and the push to move road...
Real Economy Year Book 2014 (PDF Report)
This edition drills down into the performance and outlook for a variety of sectors, including automotive, construction, electricity, transport, steel, water, coal, gold, iron-ore and platinum.
Real Economy Insight: Automotive 2014 (PDF Report)
This four-page brief covers key developments in the automotive industry over the past 12 months, including an overview of South Africa’s automotive market, trade figures, production and the policies influencing the sector.
Real Economy Insight: Construction 2014 (PDF Report)
This five-page brief covers key developments in the construction industry over the past 12 months. It provides an overview of the sector and includes details of employment in the sector, infrastructure and municipal spending, as well as insight into companies’...
Real Economy Insight: Electricity 2014 (PDF Report)
This five-page brief covers key developments in the electricity industry over the past 12 months, including details of State-owned power utility Eskom’s generation activities, funding and tariffs, independent power producers and prospects for the sector.
This Week's Magazine
Integrated energy and chemical company Sasol has partnered with Unisa Graduate School of Business Leadership (SBL) professor and founder and CEO of PanAvest Partnership Dr Douglas Boateng to publish a series of books on executive supply chain management aimed at...
The World Wide Fund for Nature’s (WWF’s) 2014 Living Planet Index (LPI) indicates that there has been a 52% decline in vertebrate species since 1970. The Index tracked the trends of 10 000 discrete populations of over 3000 vertebrate species between 1970 and 2010.
Rwanda has joined a number of East African countries seeking to import electricity from Ethiopia as its demand grows. After it became apparent several generation project it is implementing will not come on stream early enough, now plans to import 400 MW from Ethiopia...
Metrorail’s first new passenger train will arrive in November next year, says Passenger Rail Agency of South Africa (PRASA) CEO Lucky Montana. “Next year we will be able to put our hands around the infrastructure and equipment we have been talking about for so long.”
The Competition Commission has launched an investigation into what it says are “price fixing, market division and collusive tendering in the market for the manufacture and supply of automotive components to original equipment manufacturers” (OEMs, or vehicle...